TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Blood Transfusion Diagnostics Market – By Product
1.3.2 SAM Blood Transfusion Diagnostics Market – By Application
1.3.3 SAM Blood Transfusion Diagnostics Market – By End User
1.3.4 SAM Blood Transfusion Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Blood Transfusion Diagnostics Market – Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. SAM Blood Transfusion Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rapid Increase in Chronic Diseases
5.1.2 Need for Blood Transfusion due to Rise in Organ Transplants Surgeries
5.2 Market Restraints
5.2.1 Problems associated with Blood Transfusion Services
5.3 Market Opportunities
5.3.1 Elevated Healthcare Expenditure in Emerging Economies
5.4 Future Trends
5.4.1 Technological Developments in Blood Transfusion Diagnostics
5.5 Impact Analysis
6. Blood Transfusion Diagnostics Market– SAM Analysis
6.1 SAM Blood Transfusion Diagnostics Market Revenue Forecast and Analysis
7. SAM Blood Transfusion Diagnostics Market Analysis – By Product
7.1 Overview
7.2 SAM Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
7.3 Instruments and Kits
7.3.1 Overview
7.3.2 Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
7.4 Reagents
7.4.1 Overview
7.4.2 Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
8. SAM Blood Transfusion Diagnostics Market Analysis – By Application
8.1 Overview
8.2 SAM Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
8.3 Disease Screening
8.3.1 Overview
8.3.2 Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
8.4 Blood Grouping
8.4.1 Overview
8.4.2 Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9. SAM Blood Transfusion Diagnostics Market Analysis – By End User
9.1 Overview
9.2 SAM Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028, (%)
9.3 Blood Banks
9.3.1 Overview
9.3.2 Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals
9.4.1 Overview
9.4.2 Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.6 Plasma Fractionation Companies
9.6.1 Overview
9.6.2 Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
10. SAM Blood Transfusion Diagnostics Market Analysis – Country Analysis
10.1 SAM Blood Transfusion Diagnostics Market
10.1.1 Overview
10.1.3 SAM: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.3.1 Brazil: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1.1 Overview
10.1.3.1.1 Brazil Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.1.2 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.3.1.3 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.1.3.1.4 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.1.3.2 Argentina: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2.1 Overview
10.1.3.2.2 Argentina Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.2.3 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.3.2.4 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.1.3.2.5 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.1.3.3 Rest of the SAM: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.3.1 Overview
10.1.3.3.2 Rest of the SAM Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.3.3 Rest of SAM: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.3.3.4 Rest of SAM: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.1.3.3.5 Rest of SAM: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Grifols, S.A.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Immucor, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Ortho Clinical Diagnostics (QuidelOrtho Corporation)
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DiaSorin S.p.A.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Quotient Limited
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 BAG Diagnostics GmbH
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms